Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy
Open Access
- 4 August 2022
- journal article
- review article
- Published by MDPI AG in Nanomaterials
- Vol. 12 (15) , 2672
Abstract
Cancer therapies have advanced tremendously throughout the last decade, yet multiple factors still hinder the success of the different cancer therapeutics. The traditional therapeutic approach has been proven insufficient and lacking in the suppression of tumor growth. The simultaneous delivery of multiple small-molecule chemotherapeutic drugs and genes improves the effectiveness of each treatment, thus optimizing efficacy and improving synergistic effects. Nanomedicines integrating inorganic, lipid, and polymeric-based nanoparticles have been designed to regulate the spatiotemporal release of the encapsulated drugs. Multidrug-loaded nanocarriers are a potential strategy to fight cancer and the incorporation of co-delivery systems as a feasible treatment method has projected synergistic benefits and limited undesirable effects. Moreover, the development of co-delivery systems for maximum therapeutic impact necessitates better knowledge of the appropriate therapeutic agent ratio as well as the inherent heterogeneity of the cancer cells. Co-delivery systems can simplify clinical processes and increase patient quality of life, even though such systems are more difficult to prepare than single drug delivery systems. This review highlights the progress attained in the development and design of nano carrier-based co-delivery systems and discusses the limitations, challenges, and future perspectives in the design and fabrication of co-delivery systems.Keywords
Funding Information
- Dana Gas Endowed Chair for Chemical Engineering, American University of Sharjah (FRG20-L-E48, eFRG18-BBRCEN-03, MRG/18/2020)
- Sheikh Hamdan Award for Medical Sciences (FRG20-L-E48, eFRG18-BBRCEN-03, MRG/18/2020)
- Friends of Cancer Patients (FoCP) (FRG20-L-E48, eFRG18-BBRCEN-03, MRG/18/2020)
This publication has 174 references indexed in Scilit:
- Drug-Loaded Fluorescent Cubosomes: Versatile Nanoparticles for Potential Theranostic ApplicationsLangmuir, 2013
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsEuropean Journal of Pharmaceutical Sciences, 2013
- Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicinInternational Journal of Nanomedicine, 2012
- Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAsInternational Journal of Nanomedicine, 2012
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNature Nanotechnology, 2011
- Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamideBiomaterials, 2011
- Singlet oxygen mediated DNA degradation by copper nanoparticles: potential towards cytotoxic effect on cancer cellsJournal of Nanobiotechnology, 2011
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer TherapyMolecular Therapy, 2010
- Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of OxaliplatinJournal of the American Chemical Society, 2010
- Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInternational Journal of Nanomedicine, 2009